← FDA DRUG APPROVALS

FDA ANDA · ANDA090056

DONEPEZIL HYDROCHLORIDE

Sponsor: AUROBINDO

APPLICATION
ANDA090056
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-31
LATEST ACTION
2019-05-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 5MG · TABLET · ORAL
DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2019-05-21Labeling · Supplement 10 · standardAP
2015-11-30Labeling · Supplement 8 · standardAP
2014-10-26Labeling · Supplement 6 · standardAP
2013-07-25Labeling · Supplement 3 · standardAP
2011-05-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →